Zobrazeno 1 - 10
of 1 224
pro vyhledávání: '"Refractory Disease"'
Autor:
Gilberto Cincinelli, Gabriella Maioli, Cristina Posio, Ennio Giulio Favalli, Francesca Ingegnoli, Roberto Caporali
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-12 (2024)
Abstract Background The current EULAR definition of difficult-to-treat rheumatoid arthritis (D2T-RA) identifies patients with active disease refractory to multiple treatments at a single time point, without considering the persistence of this conditi
Externí odkaz:
https://doaj.org/article/f2a5d519594d4459a17ea37fe7672d51
Publikováno v:
Journal of Blood Medicine, Vol Volume 15, Pp 407-419 (2024)
Jing Wang,1,* Lei Tian,2,* Weilong Zhang,1,* Shuhan Tang,1 Wei Zhao,1 Yu Guo,1 Chaoling Wu,1 Yuansheng Lin,1 Xiaoyan Ke,1 Hongmei Jing1 1Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing, 100191
Externí odkaz:
https://doaj.org/article/0c857ff6997545e5a7c314970eb40843
Autor:
Irina V. Poddubnaya, Lali G. Babicheva
Publikováno v:
Современная онкология, Vol 26, Iss 2, Pp 140-148 (2024)
Background. Non-Hodgkin's lymphomas (NHL) are a heterogeneous group of hematological malignancies, the vast majority of which are B-cell tumors. The most common variant of NHL is diffuse large B-cell lymphoma (DLBCL), characterized by an aggressive c
Externí odkaz:
https://doaj.org/article/451bfc2dfc7241a99a818c6b5ea80db3
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTPatients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) require additional treatments, especially those not eligible or not responding to high dose cytotoxic chemotherapy and stem cell transplantation. Over the last f
Externí odkaz:
https://doaj.org/article/67c75f5223d94dd089953e5ef432e992
Autor:
Irene Dogliotti, Veronica Peri, Michele Clerico, Francesco Vassallo, Davide Musto, Silvio Mercadante, Simone Ragaini, Barbara Botto, Mario Levis, Mattia Novo, Marco Ghislieri, Luca Molinaro, Umberto Mortara, Chiara Consoli, Alessio Lonardo, Giulia Bondielli, Simone Ferrero, Roberto Freilone, Umberto Ricardi, Benedetto Bruno, Federica Cavallo
Publikováno v:
Cancer Medicine, Vol 13, Iss 14, Pp n/a-n/a (2024)
Abstract Background Relapse and refractory (R/R) rates after first‐line R‐CHOP in diffuse large B cell lymphomas (DLBCL) are ~40% and ~15% respectively. Aims We conducted a retrospective real‐world analysis aimed at evaluating clinical outcomes
Externí odkaz:
https://doaj.org/article/1d7d6e20f9ba4f66901f58389b759e04
Autor:
Harry Cridge, Valerie Johnson
Publikováno v:
Animals, Vol 14, Iss 19, p 2905 (2024)
Mesenchymal stem cells (MSCs) have significant anti-inflammatory properties and are beneficial in rodent models of pancreatitis. The safety and efficacy of MSCs is unknown in dogs with acute pancreatitis (AP). Dogs with AP who were treated with MSCs
Externí odkaz:
https://doaj.org/article/0e23eb4629114fb385d87b4385c30e67
Autor:
Giacomo Casalini, Andrea Giacomelli, Laura Galimberti, Riccardo Colombo, Laura Milazzo, Dario Cattaneo, Antonio Castelli, Spinello Antinori
Publikováno v:
Journal of Fungi, Vol 10, Iss 9, p 639 (2024)
We present a challenging case of a patient admitted to an intensive care unit with influenza-associated pulmonary aspergillosis (IAPA). The clinical course was characterised by refractory fungal pneumonia and tracheobronchitis, suspected drug-induced
Externí odkaz:
https://doaj.org/article/9418687e58ad47e9875ee7535b53175a
Autor:
Lourdes Hontecillas-Prieto, Daniel J. García-Domínguez, Natalia Palazón-Carrión, Alejandro Martín García-Sancho, Esteban Nogales-Fernández, Carlos Jiménez-Cortegana, María L. Sánchez-León, Silvia Silva-Romeiro, Rocío Flores-Campos, Fernando Carnicero-González, Eduardo Ríos-Herranz, Fátima de la Cruz-Vicente, Guillermo Rodríguez-García, Rubén Fernández-Álvarez, Natividad Martínez-Banaclocha, Josep Gumà-Padrò, José Gómez-Codina, Antonio Salar-Silvestre, Delvys Rodríguez-Abreu, Laura Gálvez-Carvajal, Jorge Labrador, María Guirado-Risueño, Mariano Provencio-Pulla, Margarita Sánchez-Beato, Lejeune Marylene, Tomás Álvaro-Naranjo, María Casanova-Espinosa, Antonio Rueda-Domínguez, Víctor Sánchez-Margalet, Luis de la Cruz-Merino
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundDiffuse large B cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma worldwide. DLBCL is an aggressive disease that can be cured with upfront standard chemoimmunotherapy schedules. However, in approximately 35-40% of the patients D
Externí odkaz:
https://doaj.org/article/212d6baeaf2d4c8bb7bf0ab05ba40793
Autor:
Ya-Ning Huang, Chien-Yu Lin, Hsin Chi, Nan-Chang Chiu, Daniel Tsung-Ning Huang, Lung Chang, Yen-Hsin Kung, Ching-Ying Huang
Publikováno v:
Frontiers in Pediatrics, Vol 11 (2024)
BackgroundA jaundice-predominant presentation of Kawasaki disease (KD) is atypical.MethodsA total of 12 children with KD with a predominant manifestation of jaundice at MacKay Children's Hospital were reviewed, along with 42 cases reported in the lit
Externí odkaz:
https://doaj.org/article/8c45d4eda33a429791d0053d17a31fd3
Autor:
Gianmarco Bagnato, Vittorio Stefoni, Alessandro Broccoli, Lisa Argnani, Cinzia Pellegrini, Beatrice Casadei, Francesca Bonifazi, Pier Luigi Zinzani
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 16, Iss 1 (2024)
We report the case of 2 patients with relapsed/refractory peripheral T-cell lymphoma treated with valemetostat tosilate, a selective dual inhibitor of histone-lysine N-methyltransferases enhancer of zeste homolog 1 and 2, and subsequently bridged to
Externí odkaz:
https://doaj.org/article/f3bcfe6454db4c48926e6d674464f884